188 related articles for article (PubMed ID: 35623563)
1. Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration.
Mei L; Yu M; Liu Y; Weh E; Pawar M; Li L; Besirli CG; Schwendeman AA
Nanomedicine; 2022 Aug; 44():102571. PubMed ID: 35623563
[TBL] [Abstract][Full Text] [Related]
2. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.
Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A
Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623
[No Abstract] [Full Text] [Related]
3. Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.
Fawaz MV; Kim SY; Li D; Ming R; Xia Z; Olsen K; Pogozheva ID; Tesmer JJG; Schwendeman A
J Pharmacol Exp Ther; 2020 Feb; 372(2):193-204. PubMed ID: 31776208
[TBL] [Abstract][Full Text] [Related]
4. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
[TBL] [Abstract][Full Text] [Related]
5. Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.
Li D; Fawaz MV; Morin EE; Ming R; Sviridov D; Tang J; Ackermann R; Olsen K; Remaley AT; Schwendeman A
Mol Pharm; 2018 Jan; 15(1):83-96. PubMed ID: 29141139
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.
Kelly UL; Grigsby D; Cady MA; Landowski M; Skiba NP; Liu J; Remaley AT; Klingeborn M; Bowes Rickman C
J Biol Chem; 2020 Sep; 295(39):13601-13616. PubMed ID: 32737203
[TBL] [Abstract][Full Text] [Related]
7. Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport.
Yuan W; Yu B; Yu M; Kuai R; Morin EE; Wang H; Hu D; Zhang J; Moon JJ; Chen YE; Guo Y; Schwendeman A
J Control Release; 2021 Jan; 329():361-371. PubMed ID: 33188828
[TBL] [Abstract][Full Text] [Related]
8. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
[TBL] [Abstract][Full Text] [Related]
9. Cerium oxide nanoparticles reduce the accumulation of autofluorescent deposits in light-induced retinal degeneration: Insights for age-related macular degeneration.
Tisi A; Passacantando M; Lozzi L; Maccarone R
Exp Eye Res; 2020 Oct; 199():108169. PubMed ID: 32758489
[TBL] [Abstract][Full Text] [Related]
10. Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo.
Yuan W; Ernst K; Kuai R; Morin EE; Yu M; Sviridov DO; Tang J; Mei L; Li D; Ackermann R; Remaley AT; Schwendeman A
Nanomedicine; 2023 Feb; 48():102646. PubMed ID: 36549559
[TBL] [Abstract][Full Text] [Related]
11. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.
Tang J; Kuai R; Yuan W; Drake L; Moon JJ; Schwendeman A
Nanomedicine; 2017 Aug; 13(6):1869-1878. PubMed ID: 28434931
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
13. Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells.
Biswas L; Zeng Z; Graham A; Shu X
Exp Eye Res; 2020 Feb; 191():107931. PubMed ID: 31931003
[TBL] [Abstract][Full Text] [Related]
14. Phospholipids impact the protective effects of HDL-mimetic nanodiscs against lipopolysaccharide-induced inflammation.
Kim SY; Kang J; Fawaz MV; Yu M; Xia Z; Morin EE; Mei L; Olsen K; Li XA; Schwendeman A
Nanomedicine (Lond); 2023 Dec; 18(29):2127-2142. PubMed ID: 38197376
[TBL] [Abstract][Full Text] [Related]
15. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration.
Zhang J; Bai Y; Huang L; Qi Y; Zhang Q; Li S; Wu Y; Li X
Cell Death Dis; 2015 Nov; 6(11):e1972. PubMed ID: 26561782
[TBL] [Abstract][Full Text] [Related]
17. Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.
Subramanian C; Kuai R; Zhu Q; White P; Moon JJ; Schwendeman A; Cohen MS
Surgery; 2016 Jan; 159(1):284-94. PubMed ID: 26582501
[TBL] [Abstract][Full Text] [Related]
18. Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.
Tang J; Li D; Drake L; Yuan W; Deschaine S; Morin EE; Ackermann R; Olsen K; Smith DE; Schwendeman A
J Lipid Res; 2017 Jan; 58(1):124-136. PubMed ID: 27881716
[TBL] [Abstract][Full Text] [Related]
19. Retinal pigment epithelium cholesterol efflux mediated by the 18 kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration.
Biswas L; Zhou X; Dhillon B; Graham A; Shu X
Hum Mol Genet; 2017 Nov; 26(22):4327-4339. PubMed ID: 28973423
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products-related modulation of cathepsin L and NF-κB signalling effectors in retinal pigment epithelium lead to augmented response to TNFα.
Sharif U; Mahmud NM; Kay P; Yang YC; Harding SP; Grierson I; Kamalden TA; Jackson MJ; Paraoan L
J Cell Mol Med; 2019 Jan; 23(1):405-416. PubMed ID: 30338926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
